Quintiles and Quest Diagnostics have entered a definitive agreement to form a global clinical trials laboratory services business by combining clinical lab operations. The joint venture will offer an expanded range of services and test menu to customers across all segments of the biopharmaceutical industry. Quintiles will own 60% and Quest Diagnostics will own 40%. A global management team will be appointed to lead the new business.   The JV combines Quintiles’ scale, clinical trial expertise, a...